Europe - FRA:SRT3 - DE0007165631
The current stock price of SRT3.DE is 229 EUR. In the past month the price increased by 18.56%. In the past year, price decreased by -3.33%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.41 | 172.00B | ||
DAP.DE | DANAHER CORP | 28.66 | 131.75B | ||
1DHR.MI | DANAHER CORP | 28.66 | 131.68B | ||
LO3.DE | LONZA GROUP AG-REG | 35.74 | 41.65B | ||
QTS.DE | IQVIA HOLDINGS INC | 17.93 | 29.81B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 48.09 | 19.33B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 47.26 | 19.00B | ||
SRT.DE | SARTORIUS AG | 42.34 | 13.79B | ||
ILU.DE | ILLUMINA INC | 24.02 | 13.11B | ||
ERF.PA | EUROFINS SCIENTIFIC | 17.47 | 11.46B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 17.25 | 11.31B | ||
QIA.DE | QIAGEN N.V. | 19.87 | 8.62B |
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,685 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
SARTORIUS AG-VORZUG
Otto-Brenner-Str. 20
Goettingen NIEDERSACHSEN DE
Employees: 13685
Phone: 495513080
The current stock price of SRT3.DE is 229 EUR. The price increased by 3.53% in the last trading session.
The exchange symbol of SARTORIUS AG-VORZUG is SRT3 and it is listed on the Deutsche Boerse Ag exchange.
SRT3.DE stock is listed on the Deutsche Boerse Ag exchange.
8 analysts have analysed SRT3.DE and the average price target is 314.94 EUR. This implies a price increase of 37.53% is expected in the next year compared to the current price of 229. Check the SARTORIUS AG-VORZUG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SARTORIUS AG-VORZUG (SRT3.DE) has a market capitalization of 17.15B EUR. This makes SRT3.DE a Large Cap stock.
SARTORIUS AG-VORZUG (SRT3.DE) currently has 13685 employees.
SARTORIUS AG-VORZUG (SRT3.DE) has a support level at 206.9 and a resistance level at 229.01. Check the full technical report for a detailed analysis of SRT3.DE support and resistance levels.
The Revenue of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 5.14% in the next year. Check the estimates tab for more information on the SRT3.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SARTORIUS AG-VORZUG (SRT3.DE) has a dividend yield of 0.41%. The yearly dividend amount is currently 0.74. Check the full fundamental report for a detailed analysis of SRT3.DE dividend history, reliability and sustainability.
SARTORIUS AG-VORZUG (SRT3.DE) will report earnings on 2025-10-16.
The PE ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 52.64. This is based on the reported non-GAAP earnings per share of 4.35 and the current share price of 229 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SRT3.DE.
ChartMill assigns a technical rating of 5 / 10 to SRT3.DE. When comparing the yearly performance of all stocks, SRT3.DE is a bad performer in the overall market: 67.78% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE. SRT3.DE may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months SRT3.DE reported a non-GAAP Earnings per Share(EPS) of 4.35. The EPS increased by 33.21% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3% | ||
ROA | 1.04% | ||
ROE | 3.92% | ||
Debt/Equity | 1.54 |
8 analysts have analysed SRT3.DE and the average price target is 314.94 EUR. This implies a price increase of 37.53% is expected in the next year compared to the current price of 229.
For the next year, analysts expect an EPS growth of 23.27% and a revenue growth 5.14% for SRT3.DE